In the midst of a volatile market environment, where major stock indexes have shown resilience despite concerns about an AI bubble and ongoing government shutdown, investors are increasingly looking at companies with strong insider ownership as potential opportunities. Such stocks often signal confidence from those closest to the company's operations and can be particularly attractive in uncertain times, making Viemed Healthcare and two other insider-owned growth stocks worth watching.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Upstart Holdings (UPST) | 12.6% | 92.9% |
| Niu Technologies (NIU) | 37.2% | 92.8% |
| FTC Solar (FTCI) | 23.1% | 63% |
| Credo Technology Group Holding (CRDO) | 10.9% | 30.4% |
| Celsius Holdings (CELH) | 10.8% | 31.8% |
| Bitdeer Technologies Group (BTDR) | 37.3% | 94.3% |
| Atour Lifestyle Holdings (ATAT) | 18.2% | 23.7% |
| Astera Labs (ALAB) | 12.1% | 31.1% |
| AppLovin (APP) | 27.5% | 25.6% |
| Accelerant Holdings (ARX) | 24.9% | 66.1% |
Let's take a closer look at a couple of our picks from the screened companies.
Viemed Healthcare (VMD)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Viemed Healthcare, Inc. operates in the United States, offering home medical equipment and post-acute respiratory healthcare services, with a market cap of approximately $253.66 million.
Operations: The company's revenue primarily comes from its healthcare facilities and services segment, generating $240.88 million.
Insider Ownership: 13.1%
Revenue Growth Forecast: 16.7% p.a.
Viemed Healthcare's earnings grew by 47.6% last year, with future earnings expected to grow significantly at 22.8% annually, outpacing the US market. Although insider selling has been significant recently, the company completed a buyback of 5% shares for US$13.2 million and raised its revenue guidance to between US$271 million and US$277 million for 2025. Its P/E ratio of 18.1x is below the healthcare industry average, indicating potential value relative to peers.
- Dive into the specifics of Viemed Healthcare here with our thorough growth forecast report.
- Our valuation report unveils the possibility Viemed Healthcare's shares may be trading at a premium.
QuantaSing Group (QSG)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: QuantaSing Group Limited designs and sells pop toys, with a market cap of $394.29 million.
Operations: The company generates revenue from its Pop Toy Business (CN¥65.78 million), Consumer Business (CN¥213.20 million), and Learning Service and Others (CN¥2.45 billion).
Insider Ownership: 33.8%
Revenue Growth Forecast: 10.4% p.a.
QuantaSing Group, soon to be Here Group Limited, is poised for significant earnings growth at 26.5% annually over the next three years, surpassing US market averages. Despite a recent decline in sales and net income compared to the previous year, the company trades at good value relative to its industry peers. With no substantial insider trading activity reported recently and a completed buyback of 3.19% shares for $3.6 million, QuantaSing maintains robust insider ownership dynamics.
- Take a closer look at QuantaSing Group's potential here in our earnings growth report.
- Our comprehensive valuation report raises the possibility that QuantaSing Group is priced lower than what may be justified by its financials.
Vital Farms (VITL)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Vital Farms, Inc. is a food company that packages, markets, and distributes shell eggs, butter, and other products in the United States with a market cap of approximately $1.44 billion.
Operations: Vital Farms generates revenue through the packaging, marketing, and distribution of shell eggs, butter, and other products in the United States.
Insider Ownership: 17%
Revenue Growth Forecast: 19.2% p.a.
Vital Farms demonstrates robust growth potential with a 19.2% annual revenue increase forecasted, outpacing the US market's 10.5%. The company's recent earnings report shows strong performance, with Q3 sales reaching US$198.94 million and net income doubling compared to last year. Insider ownership remains significant, although recent months have seen substantial insider selling without corresponding buying activity. Analysts agree on a potential stock price rise of 43.7%, reflecting confidence in its growth trajectory.
- Delve into the full analysis future growth report here for a deeper understanding of Vital Farms.
- Our expertly prepared valuation report Vital Farms implies its share price may be too high.
Make It Happen
- Reveal the 206 hidden gems among our Fast Growing US Companies With High Insider Ownership screener with a single click here.
- Ready For A Different Approach? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Vital Farms might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com